How To Enter

Initiatives are invited from individuals or teams working in the hepatitis C arena in the UK. Whatever the area of patient care, if your initiative or programme relates to hepatitis C in any way, you should enter. Judges are keen to review a wide spectrum of entries and recognise the good practice that we know is out there.

2017 awards programme to be annouced.

Why should I enter?

You can help other teams in their quest to improve patient outcomes by sharing your successes and key learnings.

How do I enter?

The entry process is simple so entering will not take up too much time.

  1. Download an entry form and save to your computer. 
  2. Complete your entry taking into account category descriptions and judging criteria.
  3. Email your entry and supplementary materials to

Need help?

Writing an effective QiC entry takes careful planning. To help your entry shine through, please download the QiC Seven Steps to Success, which offers advice and guidance on how to make your entry stand out.

Problems downloading the entry form?

If you are unable to download the form due to your company's firewall or anti-virus settings, please contact Debbie Tuesley on or +44 (0)1372 414253 and the form will be emailed directly to you.

What happens next?

Each entry will be reviewed by a panel of high-level hepatitis C experts and scored against the judging criteria.

Finalists will be notified and then invited to hear the winners announced on at an awards presentation.

At the awards presentation, finalists and winners in each category will be presented with a certificate and/or a trophy.

Finalists will be featured on QiC Connect, an online knowledge hub packed full of examples of healthcare initiatives that have been successfully implemented by health providers and others.


2017 eligibility to be announced

Entry fee

There is no charge to enter QiC Hepatitis C.


PMGroup will keep all information provided confidential. All judges sign a confidentiality agreement prior to appointment. Entrants may mark certain sensitive parts of their entry 'not for publication', provided such restrictions are not used unreasonably.

QiC Hepatitis C is supported by: